Table 3 Follow-up and post-operative complications
Planned post-operative follow-up | |
Phone call alone | 605 (93.2%) |
Face-to-face appointment (e.g. toric lens, dexamethasone implant, iStent, intra-op complication) | 44 (6.8%) |
Post-operative complications within 30 day period | |
None | 601 (92.6%) |
Floaters/uncomplicated posterior vitreous detachment | 11 (1.7%) |
Corneal oedema | 8 (1.2%) |
Ocular surface disorder | 8 (1.2%) |
Blurred vision but no abnormality detected | 5 (0.8%) |
Raised intraocular pressure | 5 (0.8%) |
Macular oedema | 4 (0.6%) |
Dysphotopsia | 2 (0.3%) |
Central retinal vein occlusion | 2 (0.3%) |
Posterior capsular opacification | 1 (0.2%) |
Refractive surprise | 1 (0.2%) |
Retained lens matter | 1 (0.2%) |
Face-to-face appointment within 30 days post-op (including routine appointments) | |
No | 565 (87.1%) |
Yes | 84 (12.9%) |
Planned: 44 (6.8%) | |
Unplanned: 40 (6.2%) | |
Number of appointments | |
1: 60 (9.2%) | |
2: 9 (1.4%) | |
3: 10 (1.5%) | |
4: 4 (0.6%) | |
5: 1 (0.2%) | |
Further operation within 30 days post-op | 3 (0.5%) Vitrectomy + secondary IOL insertion: 2 (0.3%) AC washout: 1 (0.2%) |
Duration between symptoms and being reviewed in clinic | |
Average (SD) | 4.5 (3.47) |
Range | 0-14d |
0 days | 5 (12.5%) |
1–3 days | 14 (35%) |
4–7 days | 16 (40%) |
8–14 days | 5 (12.5%) |
Unplanned face-to-face appointments ‘I had difficulty being seen regarding my post-operative symptoms’ | 40 (6.2%) |
Strongly agree | 4 (10%) |
Agree | 2 (5%) |
Neutral | 8 (20%) |
Disagree | 6 (15%) |
Strongly disagree | 20 (50%) |